Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Uppsala
Clinical trial register · Sweden

Clinical Trials in Uppsala, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 15 Solna 14 Gothenburg 13 Lund 5 Uppsala 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Uppsala University71 AstraZeneca25 Karolinska Institutet20 Merck Sharp & Dohme LLC18 Uppsala University Hospital16 Clear sponsor filter
Site location
Stockholm15 Solna14 Gothenburg13 Lund5 Uppsala5
All 22 locations
Target enrolment
to

Trials with a site in Uppsala

5 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Active, closed
AbbVie
Observational
427
Stockholm, Uppsala, Gothenburg
2024-01-24
Active, closed
AbbVie
Phase 1
21
Uppsala, Örebro
2020-11-11
Active, closed
AbbVie
Phase 3
964
Malmö, Falun, Solna, Uppsala, Västerås, Örebro
2019-03-25
Active, closed
AbbVie
Phase 3
443
Uppsala, Uddevalla, Lund, Stockholm
2017-02-02
Active, closed
AbbVie
Observational
8,250
Solna, Stockholm, Uppsala, Gothenburg, Skövde
2013-04-29
Rows per page Showing 1–5 of 5
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/uppsala

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5 of those studies with a site in Uppsala that also match the filters currently applied.

How many clinical trials are recruiting in Uppsala?

0 of the 5 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Uppsala), 5 studies
PhaseStudiesRecruitingShare
Observational2040%
Phase 32040%
Phase 11020%

Most active sponsors

Lead sponsors with the most studies (Uppsala)
Lead sponsorStudiesRecruiting
AbbVie50
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.